Catalyst Wire Dossier Catalyst Wire Dossier

AFINITOR DISPERZ

everolimus · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for AFINITOR DISPERZ, covering 2012-08-29 to 2024-03-11. Get the full timeline:

Most recent: FDA Approved: AFINITOR DISPERZ — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing